These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20712727)

  • 1. Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort.
    Cadenhead KS; Addington J; Cannon T; Cornblatt B; McGlashan T; Perkins D; Seidman L; Tsuang M; Walker E; Woods S; Heinssen R
    Early Interv Psychiatry; 2010 Aug; 4(3):220-6. PubMed ID: 20712727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample.
    Walker EF; Cornblatt BA; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Heinssen R
    Schizophr Res; 2009 Nov; 115(1):50-7. PubMed ID: 19709859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Precedes Positive Symptoms in North American Adolescent and Young Adult Clinical High Risk Cohort.
    Woodberry KA; Seidman LJ; Bryant C; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Mathalon DH; Perkins DO; Tsuang MT; Walker EF; Woods SW
    J Clin Child Adolesc Psychol; 2018; 47(1):69-78. PubMed ID: 27705009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of violent behaviour in young people at clinical high risk for psychosis from the North American Prodrome Longitudinal Studies consortium.
    Tronick LN; Mirzakhanian H; Addington J; Bearden CE; Cannon TD; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Stone W; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
    Early Interv Psychiatry; 2023 Aug; 17(8):759-770. PubMed ID: 36627192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium.
    Alderman T; Addington J; Bearden C; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
    Early Interv Psychiatry; 2015 Dec; 9(6):467-75. PubMed ID: 24576057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intervention in individuals at ultra-high risk for psychosis: a review and future directions.
    McGorry PD; Nelson B; Amminger GP; Bechdolf A; Francey SM; Berger G; Riecher-Rössler A; Klosterkötter J; Ruhrmann S; Schultze-Lutter F; Nordentoft M; Hickie I; McGuire P; Berk M; Chen EY; Keshavan MS; Yung AR
    J Clin Psychiatry; 2009 Sep; 70(9):1206-12. PubMed ID: 19573499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study.
    Woods SW; Addington J; Cadenhead KS; Cannon TD; Cornblatt BA; Heinssen R; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; McGlashan TH
    Schizophr Bull; 2009 Sep; 35(5):894-908. PubMed ID: 19386578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of the retrospectively assessed prodromal period in hospitalized patients with first-episode nonaffective psychosis: findings from a socially disadvantaged, low-income, predominantly African American population.
    Compton MT; Goulding SM; Walker EF
    J Clin Psychiatry; 2010 Oct; 71(10):1279-85. PubMed ID: 20492836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study.
    Walker EF; Trotman HD; Pearce BD; Addington J; Cadenhead KS; Cornblatt BA; Heinssen R; Mathalon DH; Perkins DO; Seidman LJ; Tsuang MT; Cannon TD; McGlashan TH; Woods SW
    Biol Psychiatry; 2013 Sep; 74(6):410-7. PubMed ID: 23562006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection for psychosocial treatment for youth at clinical high risk for psychosis based on the North American Prodrome Longitudinal Study individualized risk calculator.
    Worthington MA; Miklowitz DJ; O'Brien M; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cannon TD
    Early Interv Psychiatry; 2021 Feb; 15(1):96-103. PubMed ID: 31943807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive validity of clinical variables in the "at risk" for psychosis population: international comparison with results from the North American Prodrome Longitudinal Study.
    Thompson A; Nelson B; Yung A
    Schizophr Res; 2011 Mar; 126(1-3):51-7. PubMed ID: 21035313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Severity-Based Clinical Staging Model for the Psychosis Prodrome: Longitudinal Findings From the New York Recognition and Prevention Program.
    Carrión RE; Correll CU; Auther AM; Cornblatt BA
    Schizophr Bull; 2017 Jan; 43(1):64-74. PubMed ID: 28053131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America.
    Cannon TD; Cadenhead K; Cornblatt B; Woods SW; Addington J; Walker E; Seidman LJ; Perkins D; Tsuang M; McGlashan T; Heinssen R
    Arch Gen Psychiatry; 2008 Jan; 65(1):28-37. PubMed ID: 18180426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.
    Addington J; Liu L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; McGlashan TH
    J Nerv Ment Dis; 2015 May; 203(5):328-35. PubMed ID: 25919383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
    Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
    Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Pre-onset Subthreshold Psychotic Symptoms With Longitudinal Outcomes During Treatment of a First Episode of Psychosis.
    Rosengard RJ; Malla A; Mustafa S; Iyer SN; Joober R; Bodnar M; Lepage M; Shah JL
    JAMA Psychiatry; 2019 Jan; 76(1):61-70. PubMed ID: 30304442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating young individuals at clinical high risk for psychosis.
    Marshall C; Addington J; Epstein I; Liu L; Deighton S; Zipursky RB
    Early Interv Psychiatry; 2012 Feb; 6(1):60-8. PubMed ID: 21951980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.
    Seidman LJ; Giuliano AJ; Meyer EC; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Bearden CE; Christensen BK; Hawkins K; Heaton R; Keefe RS; Heinssen R; Cornblatt BA;
    Arch Gen Psychiatry; 2010 Jun; 67(6):578-88. PubMed ID: 20530007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early psychosis detection program in Chile: A first step for the South American challenge in psychosis research.
    Gaspar PA; Castillo RI; Maturana A; Villar MJ; Ulloa K; González G; Ibaceta O; Ortiz A; Corral S; Mayol R; De Angel V; Aburto MB; Martínez A; Corcoran CM; Silva H
    Early Interv Psychiatry; 2019 Apr; 13(2):328-334. PubMed ID: 30548415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early intervention for psychosis.
    Marshall M; Rathbone J
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004718. PubMed ID: 17054213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.